[{"NetIncomeLossConverted_1_Q1_USD":977414000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":29823000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":113610000.0,"EarningsPerShareDiluted_1_Q1_USD":32.38,"StockholdersEquity_0_Q1_USD":10609059000.0,"RevenuesConverted_1_Q1_USD":726796000.0,"Assets_0_Q1_USD":13933160000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":30186000.0,"EarningsPerShareBasic_1_Q1_USD":32.77,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20210430"}]